Dermatology Diagnostic Devices And Therapeutics Market Size, Share, and Trends

Dermatology Diagnostic Devices and Therapeutics Market (By Diagnostic Devices: Dermatoscopes, Microscopes and Trichoscopes, Imaging Equipment; By Application Class: Diagnostic Devices, Treatment Devices; By End Use: Hospitals, Clinics, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032

  • Last Updated : August 2023
  • Report Code : 2409
  • Category : Healthcare

The global dermatology diagnostic devices and therapeutics market size was estimated at USD 13 billion in 2022 and is projected to hit around USD 25.69 billion by 2032 with a registered CAGR of 7.1% during the forecast period 2023 to 2032.

Dermatology diagnostic devices and therapeutics are used for diagnosing skin wounds, skin-related disorders, pigmentation acne, and assisting in the diagnosis of skin cancer. 

Dermatology Diagnostic Devices and Therapeutics Market Size 2023 To 2032

Access our Healthcare Data Intelligence Tool with 10000+ Database, Visit: Towards Healthcare

Key Takeaways

  • By diagnostic devices, the imaging equipment segment had the highest revenues in 2022 and is expected to see above-average CAGR growth of 7.96% from 2023 to 2032.
  • By application, the hair removal segment has captured a market share of 15% in 2022.
  • By end use, the hospitals' segment accounted for a market share of 54.60% in 2022.
  • The North America region contributed 45% of the revenue share in 2022.

Growth Factor

The market growth for dermatological diagnostic equipment would be greatly impacted by the rising incidence of skin cancer. UV radiation exposure is a cause of skin cancer. According to the American Academy of Dermatology, 1.9 million individuals were expected to have melanoma in 2019. Additionally, the Skin Cancer Foundation predicts a 2% increase in new melanoma occurrences in 2020. The demand for dermatological devices will also increase during the next years due to the increasing requirement for quick diagnostics of skin cancer and other associated skin problems. The size of the market for dermatological diagnostic equipment will increase over the future years due to technological developments in the field of dermatology. Manufacturers should benefit from these technical developments in order to preserve their place in the market. The adoption of dermatological diagnostic devices will also be influenced by the development of diagnostic tools for treating malignant skin cancer and other conditions like squamous cell carcinoma. Similarly to this, as dermatological diagnostic gadgets become more digitalized, more people will use them, increasing the market's growth. Therefore, the industry of dermatological diagnostic devices will have the potential for significant growth due to ongoing improvements in dermatology equipment. The market for dermatological diagnostic equipment and therapies is gaining momentum due to the proliferation of specialist clinics, in addition to the rise in cases of hair loss and skin illnesses and technological advances in the industry. Additionally, the development of e-commerce and the rise of the cosmetics industry are anticipated to have a beneficial impact on this market. On the other hand, high prices for dermatological diagnostic tools and associated treatments prevent the market from growing more profitably.

  • An increase in occurrences of hair loss, skin conditions, and scientific developments
  • An increase in patients with skin allergies, fungus infections, and skin cancer due to pollution and environmental changes.
  • A high incidence of acne and psoriasis has also been caused by rising pollution, changing lifestyles, and more cosmetic use, which has positively impacted the worldwide market.
  • The expansion of the overall market has been attributed to rising healthcare costs as well as the development of new and improved dermatological diagnostic tools, treatments, and equipment.

Dermatology Diagnostic Devices and Therapeutics Market Scope

Report Coverage Details
Market Size in 2023 USD 13.86 Billion
Market Size by 2032 USD 25.69 Billion
Growth Rate from 2023 to 2032 CAGR of 7.1%
Largest Market North America 
Fastest Growing Market Asia Pacific 
Base Year 2022
Forecast Period 2023 to 2032
Segments Covered
  • By Diagnostic Devices
  • By Application Class
  • By End Use
Regions Covered
  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa

 

Dermatology Diagnostic Devices and Therapeutics Market Dynamics

Key Market Drivers

Geriatric people are using aesthetic operations more frequently

  • The number of people 60 and older in the globe is projected to rise from 880 Mn in 2011 to 2 Bn by 2050, or 22% of the world's population. The increasing degeneration of the skin is a result of aging. Therefore, it is anticipated that older people would become more interested in cosmetic operations like skin tightening and anti-wrinkle therapy.
  • Nearly 204000 liposuction operations were carried out in the U.S. in 2019 on patients between the ages of 51 and 64, while 35000 treatments were carried out on patients 65 years of age and above, according to the American Society for Aesthetic Plastic surgery.

Increasing use of non-invasive and minimally invasive aesthetic treatments

  • The need for minimally invasive as well as non-invasive cosmetic procedures over standard surgical procedures has increased during the last decade. Alternatives that are minimally invasive or non-surgical provide a number of benefits over more common surgical techniques, including less discomfort, less scars, and speedier healing. These methods are also less costly than customary surgical treatments.
  • The market for aesthetic lasers, treatment tools, and cosmetic dermatology is all being driven by the rising demand for aesthetic operations. Such lasers are used for cosmetic operations such as skin rejuvenation, hair removal, treating psoriasis, and acne, removing tattoos, treating pigmented lesions, treating vascular lesions, and treating other skin conditions like psoriasis. The options for beauty treatments have increased thanks to lasers with lengthier wavelengths and better settings, making the aesthetic lasers market profitable.

Key Market Challenges

Clinical risks and complications associated with dermatology procedures

  • Over the past 20 years, dermatology procedures have become more and more common. The market has experienced significant growth in demand for cosmetic procedures as a result of the rise in dermatologists as well as surgeons providing safe and effective treatments as well as the development of technologically advanced items for the same. However, there are a number of potential negative effects linked to dermatological operations. 
  • Patients receiving aesthetic procedures run the risk of infection, skin irritation, pigment changes, organ damage, and anesthesia-related problems, among other things. Red light treatment devices have been blamed for causing blisters and burns, according to reports. Few people have reported getting burned after sleeping with the unit on, while others have claimed getting burned by corroded equipment or faulty wiring. It is anticipated that these issues may hinder the use of dermatological therapies.

Key Market Opportunities

Demand for minimally invasive/non-surgical procedures is rising

  • The preference for minimally invasive as well as non-invasive cosmetic procedures over traditional surgical methods has increased noticeably during the past 10 years. Compared to typical surgical techniques, minimally invasive/non-surgical therapies provide a number of benefits, such as quicker recovery and less discomfort. Additionally, these procedures are less costly than standard surgical treatments. Cosmetic dermatology, aesthetic lasers, and therapeutic devices are all being impacted by the rising demand for aesthetic procedures.

Advancements in skincare treatments

  • Over the past ten years, there has been a discernible rise in the popularity of minimally invasive as well as non-cosmetic operations over standard surgical procedures. Minimally invasive/non-surgical therapies provide a variety of advantages over conventional surgical methods, including speedier healing and reduced discomfort. These methods are also less expensive than conventional surgical procedures. The growing demand for aesthetic operations has an effect on cosmetic dermatology, aesthetic lasers, and therapeutic devices.

Diagnostic Devices Insights

The market for dermatology has been divided into imaging equipment, microscopes and trichoscopy, and dreamscapes based on diagnostic tools. The report categorizes imaging devices into optical coherence tomography, ultrasound, X-ray, magnetic resonance imaging, and magnetic resonance spectroscopy. Microscopes and trichoscopy are further divided into reflectance confocal microscopy, multispectral photoacoustic microscopy, Raman spectroscopy, and other categories. Additionally, there are three different types of dermatoscopes: hybrid, cross-polarized, and contact oil immersion. These include the sub-segments of imaging equipment, which had the highest revenues in 2022 and are expected to see above-average CAGR growth of 7.96% from 2023 to 2032. The imaging equipment market is booming as a consequence of its successful detection rates, real-time diagnostic picture production, and high sensitivity.

Application Class Insights

With a market share of over 15% in 2022, the hair removal therapy application sector will also have the fastest CAGR between 2023 to 2032. The treatment application segment is further divided into the following sub-segments: cellulite reduction, vascular and pigmented lesion removal, skin rejuvenation, hair removal, acne, psoriasis, and tattoo removal; wrinkle removal and skin resurfacing; removal of wrinkling and age spots; and others. Laser hair removal equipment in particular has been shown to be less uncomfortable and safer for all skin tones and hair colors, which is driving the expansion of this market.

End Use Insights

A major portion of the market, more than 54.60%, was accounted for by the hospital sector in 2022 due to the widespread use of cutting-edge dermatological equipment in hospital settings. Numerous visits are made to these facilities for the diagnosis and treatment of skin diseases as a result of the availability of a variety of treatment choices, which in turn promotes the segment's expansion. The end-user category for clinics is anticipated to see the fastest CAGR between 2023 to 2032. Clinics that specialize in the diagnosis and treatment of skin diseases are called dermatology offices. Certified plastic surgeons provide both surgical and nonsurgical procedures in dermatological clinics.

Dermatology Diagnostic Devices and Therapeutics Market Share, By End Use, 2022 (%)

According to TripleTree, the United States will have 14,000 dermatologists and 9,000 dermatology practices in 2020. 34% of all practices were single operations, while 48% of all operations had three or more physicians. Patients frequently attend specialty dermatological clinics for quick and efficient care as the need for specialized dermatology treatments increases, which fuels the segment's expansion. In addition, more people are attending dermatological clinics for treatment and care due to the global growth in skin cancer and melanoma prevalence and the expansion of clinics providing dermatology services.

Dermatology Diagnostic Devices and Therapeutics Market Share, By Region, 2022 (%)

Regions Revenue Share in 2022 (%)
North America 45%
Asia Pacific 16.7%
Europe 25%
Latin America 9.3%
MEA 4%


Regional Insights

The region with the highest revenue share in 2022—more than 45%—was North America. During the projection period, the regional market is expected to maintain its dominance and develop at a steady CAGR. The increased prevalence of skin cancer and other skin problems including eczema and rosacea, as well as the expanding usage of cosmetic procedures, are two major factors contributing to the regional market's development. 80% of Americans will encounter acne vulgaris at some time in their lives, and 20% of those people may have severe acne that might leave them permanently emotionally and physically damaged.

From 2023 to 2032, the Asia Pacific regional market is anticipated to develop at the quickest rate. An increase in the number of multinational corporations engaging in R&D in the Asia Pacific has shown to be a significant driver of the regional market. Rising consumer awareness of beauty is also projected to stimulate product demand, fostering regional market expansion.

Recent Developments

  • MyFiziq Ltd. has acquired a strategic equity stake in Triage, enabling the company to license Triage AI—a health assistant platform—as a SaaS offering in December 2020 that includes the capacity to do dermatological diagnoses.
  • Nikon Corporation unveiled the ECLIPSE Ci-L Plus biological microscope in September 2021. This device does not need to modify the light intensity while changing magnifications. Additionally, it boasts an ergonomic layout that eases the pressure on the body.

Dermatology Diagnostic Devices and Therapeutics Market Companies

  • Canfield Scientific, Inc.
  • Novartis International AG
  • Valeant Pharmaceuticals International, Inc.
  • gfa-Gevaert N.V.
  • Galderma S.A.
  • Michelson Diagnostics Ltd.
  • Cutera, Inc.
  • Astellas Pharma, Inc.
  • Genentech
  • GlaxoSmithKline plc
  • LEO Pharma A/S
  • Dino-Lite Europe/IDCP B.V.

Segment Covered in the Report

By Diagnostic Devices

  • Dermatoscopes
  • Microscopes and Trichoscopes
  • Imaging Equipment

By Application Class

  • Diagnostic Devices
    • Skin Cancer Diagnosis
    • Other
  • Treatment Devices
    • Hair Removal
    • Skin Rejuvenation
    • Acne, Psoriasis, and Tattoo Removal
    • Wrinkle Removal and Skin Resurfacing
    • Body Contouring and Fat Removal
    • Cellulite Reduction
    • Vascular and Pigmented Lesion Removal
    • Others

By End Use

  • Hospitals
  • Clinics
  • Others

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa (MEA)

Frequently Asked Questions

The global dermatology diagnostic devices and therapeutics market size was accounted at USD 13 billion in 2022 and it is expected to reach around USD 25.69 billion by 2032.

The global dermatology diagnostic devices and therapeutics market is poised to grow at a CAGR of 7.1% from 2023 to 2032.

The major players operating in the dermatology diagnostic devices and therapeutics market are Canfield Scientific, Inc., Novartis International AG, Valeant Pharmaceuticals International, Inc., gfa-Gevaert N.V., Galderma S.A., Michelson Diagnostics Ltd., Cutera, Inc., Astellas Pharma Inc., Genentech, GaxoSmithKline plc, LEO Pharma A/S, Dino-Lite Europe/IDCP B.V.

The driving factors of the dermatology diagnostic devices and therapeutics market are an increasing use of non-invasive and minimally invasive aesthetic treatments and the increasing use of non-invasive and minimally invasive aesthetic treatments.

North America region will lead the global dermatology diagnostic devices and therapeutics market during the forecast period 2023 to 2032.

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Dermatology Diagnostic Devices And Therapeutics Market 

5.1. COVID-19 Landscape: Dermatology Diagnostic Devices And Therapeutics Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Dermatology Diagnostic Devices And Therapeutics Market, By Diagnostic Devices

8.1. Dermatology Diagnostic Devices And Therapeutics Market, by Diagnostic Devices, 2023-2032

8.1.1 Dermatoscopes

8.1.1.1. Market Revenue and Forecast (2021-2032)

8.1.2. Microscopes and Trichoscopes

8.1.2.1. Market Revenue and Forecast (2021-2032)

8.1.3. Imaging Equipment

8.1.3.1. Market Revenue and Forecast (2021-2032)

Chapter 9. Global Dermatology Diagnostic Devices And Therapeutics Market, By Application Class

9.1. Dermatology Diagnostic Devices And Therapeutics Market, by Application Class, 2023-2032

9.1.1. Diagnostic Devices

9.1.1.1. Market Revenue and Forecast (2021-2032)

9.1.2. Treatment Devices

Chapter 10. Global Dermatology Diagnostic Devices And Therapeutics Market, By End Use 

10.1. Dermatology Diagnostic Devices And Therapeutics Market, by End Use, 2023-2032

10.1.1. Hospitals

10.1.1.1. Market Revenue and Forecast (2021-2032)

10.1.2. Clinics

10.1.2.1. Market Revenue and Forecast (2021-2032)

10.1.3. Others

Chapter 11. Global Dermatology Diagnostic Devices And Therapeutics Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Diagnostic Devices (2021-2032)

11.1.2. Market Revenue and Forecast, by Application Class (2021-2032)

11.1.3. Market Revenue and Forecast, by End Use (2021-2032)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Diagnostic Devices (2021-2032)

11.1.4.2. Market Revenue and Forecast, by Application Class (2021-2032)

11.1.4.3. Market Revenue and Forecast, by End Use (2021-2032)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Diagnostic Devices (2021-2032)

11.1.5.2. Market Revenue and Forecast, by Application Class (2021-2032)

11.1.5.3. Market Revenue and Forecast, by End Use (2021-2032)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Diagnostic Devices (2021-2032)

11.2.2. Market Revenue and Forecast, by Application Class (2021-2032)

11.2.3. Market Revenue and Forecast, by End Use (2021-2032)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Diagnostic Devices (2021-2032)

11.2.4.2. Market Revenue and Forecast, by Application Class (2021-2032)

11.2.4.3. Market Revenue and Forecast, by End Use (2021-2032)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Diagnostic Devices (2021-2032)

11.2.5.2. Market Revenue and Forecast, by Application Class (2021-2032)

11.2.5.3. Market Revenue and Forecast, by End Use (2021-2032)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Diagnostic Devices (2021-2032)

11.2.6.2. Market Revenue and Forecast, by Application Class (2021-2032)

11.2.6.3. Market Revenue and Forecast, by End Use (2021-2032)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Diagnostic Devices (2021-2032)

11.2.7.2. Market Revenue and Forecast, by Application Class (2021-2032)

11.2.7.3. Market Revenue and Forecast, by End Use (2021-2032)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Diagnostic Devices (2021-2032)

11.3.2. Market Revenue and Forecast, by Application Class (2021-2032)

11.3.3. Market Revenue and Forecast, by End Use (2021-2032)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Diagnostic Devices (2021-2032)

11.3.4.2. Market Revenue and Forecast, by Application Class (2021-2032)

11.3.4.3. Market Revenue and Forecast, by End Use (2021-2032)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Diagnostic Devices (2021-2032)

11.3.5.2. Market Revenue and Forecast, by Application Class (2021-2032)

11.3.5.3. Market Revenue and Forecast, by End Use (2021-2032)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Diagnostic Devices (2021-2032)

11.3.6.2. Market Revenue and Forecast, by Application Class (2021-2032)

11.3.6.3. Market Revenue and Forecast, by End Use (2021-2032)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Diagnostic Devices (2021-2032)

11.3.7.2. Market Revenue and Forecast, by Application Class (2021-2032)

11.3.7.3. Market Revenue and Forecast, by End Use (2021-2032)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Diagnostic Devices (2021-2032)

11.4.2. Market Revenue and Forecast, by Application Class (2021-2032)

11.4.3. Market Revenue and Forecast, by End Use (2021-2032)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Diagnostic Devices (2021-2032)

11.4.4.2. Market Revenue and Forecast, by Application Class (2021-2032)

11.4.4.3. Market Revenue and Forecast, by End Use (2021-2032)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Diagnostic Devices (2021-2032)

11.4.5.2. Market Revenue and Forecast, by Application Class (2021-2032)

11.4.5.3. Market Revenue and Forecast, by End Use (2021-2032)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Diagnostic Devices (2021-2032)

11.4.6.2. Market Revenue and Forecast, by Application Class (2021-2032)

11.4.6.3. Market Revenue and Forecast, by End Use (2021-2032)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Diagnostic Devices (2021-2032)

11.4.7.2. Market Revenue and Forecast, by Application Class (2021-2032)

11.4.7.3. Market Revenue and Forecast, by End Use (2021-2032)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Diagnostic Devices (2021-2032)

11.5.2. Market Revenue and Forecast, by Application Class (2021-2032)

11.5.3. Market Revenue and Forecast, by End Use (2021-2032)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Diagnostic Devices (2021-2032)

11.5.4.2. Market Revenue and Forecast, by Application Class (2021-2032)

11.5.4.3. Market Revenue and Forecast, by End Use (2021-2032)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Diagnostic Devices (2021-2032)

11.5.5.2. Market Revenue and Forecast, by Application Class (2021-2032)

11.5.5.3. Market Revenue and Forecast, by End Use (2021-2032)

Chapter 12. Company Profiles

12.1. Canfield Scientific, Inc.

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Novartis International AG

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Valeant Pharmaceuticals International, Inc.

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. gfa-Gevaert N.V.

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Galderma S.A.

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Michelson Diagnostics Ltd.

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Cutera, Inc.

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Astellas Pharma, Inc.

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Genentech

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. GlaxoSmithKline plc

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Proceed To Buy

USD 4900
USD 3800
USD 2100
USD 2100
USD 7500

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client